Regen BioPharma, Inc. Files Patent on Paradigm Shifting RNA/DNA-Based Approach to Cancer Immunotherapy ...Middle East

Company Combines Existing NR2F6 and Survivin Gene Silencing Findings with Second Generation Checkpoint Inhibitor Approach SAN DIEGO, Sept. 19, 2022 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced today filing of a provisional patent application with...

Hence then, the article about regen biopharma inc files patent on paradigm shifting rna dna based approach to cancer immunotherapy was published today ( Monday 19/09/2022 - 07:08 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Regen BioPharma, Inc. Files Patent on Paradigm Shifting RNA/DNA-Based Approach to Cancer Immunotherapy )

Also on site :

• Misua, Who Was Set to Appear on ‘Drag Race: Philippines’ Season 4, Dies at 27
• Telehealth giant Hims & Hers says its customer support system was hacked
• Next Level Chef’ Season 5: Who Went Home Tonight? (Night Six Elimination)